Nuformix plc
Climate Impact & Sustainability Data (2019, 2023-04-01 to 2023-09-30)
Reporting Period: 2019
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Reduced energy consumption
- Using sustainable resources
- Recycling waste
Social Achievements
- Commitment to recruitment of employees on the basis of aptitude and ability, without discrimination based on gender, orientation, origin, creed, or disability.
Governance Achievements
- Transitioned from a combined Chairman of the Board and Audit Committee to separate roles and responsibilities
- Restructured the Board and its Committee Composition
- Conducted its first Board evaluation
Climate Goals & Targets
Environmental Challenges
- Technical risks in delivering the potential of further lead programmes
- Maintaining sufficient cash flow and reliance on milestone payments
- Access to new investment given the Group’s stage of development
Mitigation Strategies
- Developing new therapies based on known drugs; operating multiple pre-clinical and clinical programmes
- Growing its pipeline of business, broadening its customer base, and securing ongoing contracts; maintaining close relationships with partners
- Communicating with existing and potential new investors
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2023-04-01 to 2023-09-30
Environmental Metrics
Environmental Challenges
- Funding the business in a competitive industry.
- Feasibility of drug candidates.
- Failure to generate and protect IP.
- Unrealistic goals and timeframes.
- Reliance on partners.
- Management, employees, consultants, and contractors.
- Business development risks in terms of timing and success of deal flow.
- Adapting to the external environment.
Mitigation Strategies
- Executing early licensing deals to generate revenue.
- Drug repurposing model to mitigate risks.
- Constant monitoring and defense of patents.
- Continual review of expectations and communications.
- Prioritizing resources on progressing its own portfolio to generate licensing revenue.
- Offering attractive remuneration and a positive working environment.
- Generating more robust data packages for licensing discussions.
- Virtual business model allowing flexible work.